Cudurka 'Myelodysplastic syndrome'
![Cudurka 'Myelodysplastic syndrome' - Daawo Cudurka 'Myelodysplastic syndrome' - Daawo](https://a.svetzdravlja.org/medical/millipede-toxin.webp)
Cudurka 'Myelodysplastic syndrome' waa koox cuduro ah marka unugyada dhiigga ee laga soo saaray dhuuxa lafta aysan u bislaan unugyada caafimaadka qaba. Tani waxay kaaga tagaysaa in yar oo unugyada dhiigga ee jidhkaaga ku jira. Unugyada dhiigga ee qaangaaray ma shaqeyn karaan si sax ah.
Cudurka Myelodysplastic syndrome (MDS) waa nooc ka mid ah kansarka. Qiyaastii saddex meelood meel dadka ah, MDS waxaa laga yaabaa inay isku beddesho halista myeloid leukemia daran.
Unugyada asliga ah ee dhuuxa lafta ayaa sameeya noocyo unugyo dhiig oo kala duwan. MDS, DNA-da ku jirta unugyada asliga ah ayaa waxyeelo soo gaartey. Sababtoo ah DNA-da ayaa waxyeello gaadhay, unugyada asliga ah ma soo saari karaan unugyo dhiig oo caafimaad qaba.
Sababta saxda ah ee MDS lama oga. Xaaladaha badankood, ma jirto sabab la yaqaan.
Waxyaabaha halista u ah MDS waxaa ka mid ah:
- Cilladaha hiddo-wadaha qaarkood
- Soo-gaadhista kiimikooyinka deegaanka ama warshadaha, bacriminta, sunta cayayaanka, dareeraha, ama biraha culus
- Sigaar cabid
Daaweynta kansarka kahor waxay kordhisaa halista MDS. Tan waxaa lagu magacaabaa heerka labaad ama daaweynta la xiriirta MDS.
- Daawooyinka qaarkood ee loo yaqaan 'chemotherapy' ayaa kordhiya fursadda lagu horumarinayo MDS. Tani waa cunsur weyn.
- Daaweynta shucaaca, marka loo isticmaalo kiimoteraabiga, waxay kordhisaa halista MDS xitaa inbadan.
- Dadka loo beddelay unugyada unugyada unugyada jirka ayaa laga yaabaa inay yeeshaan MDS maxaa yeelay waxay sidoo kale helaan qadar sare oo kiimiko ah.
MDS waxay badanaa ku dhacdaa dadka waaweyn ee jira 60 sano iyo wixii ka weyn. Waxay ku badan tahay ragga.
Marxaladda hore MDS badanaa ma laha wax astaamo ah. MDS waxaa badanaa la ogaadaa inta lagu jiro baaritaanka kale ee dhiigga.
Dadka dhiiggoodu aad u hooseeyo badanaa waxay la kulmaan astaamo. Astaamuhu waxay kuxiranyihiin nooca unuga unugga dhiiga uu kudhacay, waxaana kamid ah:
- Tabar darrida ama daalka dhiig yaraanta awgeed
- Neefta oo kugu yaraata
- Nabarro fudud iyo dhiig bax
- Dhibco yar oo casaan ama guduud ah oo maqaarka hoostiisa ah oo uu keeno dhiig bax
- Infekshanno isdaba joog ah iyo qandho
Dadka qaba MDS waxaa ku yar unugyada dhiigga. MDS waxay yareyn kartaa tirada mid ama ka badan oo ka mid ah kuwan:
- Unugyada dhiigga cas
- Unugyada dhiigga cad
- Balatarka
Qaababka unugyadan sidoo kale waa la beddeli karaa. Bixiyahaaga daryeel caafimaad ayaa sameyn doona tirinta dhiigga oo dhameystiran iyo dheecaanka dhiigga si loo ogaado nooca unugyada dhiigga ee ay saameysay.
Tijaabooyinka kale ee la qaadi karo waa:
- Himilada dhuuxa lafta iyo biopsy.
- Cytochemistry, cytometry flow, immunocytochemistry, iyo immunophenotyping baaritaanada ayaa loo isticmaalaa si loo aqoonsado loona kala saaro noocyada gaarka ah ee MDS.
- Cytogenetics iyo fluorescent in hybridization (FISH) waxaa loo isticmaalaa falanqaynta hidda-socodka. Tijaabinta cytogenetic waxay ogaan kartaa wareejinta iyo cilladaha kale ee hidde-wadaha. Kalluunka loo adeegsado in lagu aqoonsado isbeddelada gaarka ah ee koromosoomyada ku jira. Kala duwanaanshaha hidaha ayaa laga yaabaa inay gacan ka geysato go'aaminta jawaabta daaweynta.
Qaar ka mid ah tijaabooyinkan ayaa ka caawin doona bixiyahaaga inuu go'aamiyo nooca MDS ee aad haysato. Tani waxay ka caawin doontaa bixiyahaaga qorsheynta daaweyntaada.
Bixiyahaaga ayaa ku qeexi kara MDS-gaaga inuu yahay mid khatar sare, mid dhexe ah, ama halis hoose ku saleysan:
- Darnaanta yaraanta unugyada dhiigga ee jirkaaga
- Noocyada isbeddelada ku dhaca DNA-gaaga
- Tirada unugyada dhiiga cad oo aan qaan gaarin ee dhuuxa laftaada
Maaddaama ay jirto halista MDS inay isku beddesho AML, dabagal joogto ah oo lala yeesho bixiyahaaga ayaa loo baahan karaa.
Daaweyntaadu waxay ku xirnaan doontaa dhowr arrimood:
- Haddii aad khatar yar tahay ama aad khatar sare leedahay
- Nooca MDS ee aad leedahay
- Da'daada, caafimaadkaaga, iyo xaaladaha kale ee laga yaabo inaad qabtid, sida sonkorowga ama cudurka wadnaha
Ujeedada daaweynta MDS waa in laga hortago dhibaatooyinka unugyada dhiigga oo yaraaday, infekshannada iyo dhiig baxa. Waxay ka koobnaan kartaa:
- Dhiiga lagu shubo
- Daawooyinka dhiirrigeliya soo-saarka unugyada dhiigga
- Daawooyinka xakameynaya nidaamka difaaca jirka
- Dawaynta kimikada ku jirta ee hooseysa si loo hagaajiyo tirinta unugyada dhiigga
- Beerista unugyada jirridda
Bixiyahaagu wuxuu isku dayi karaa hal ama dhowr daaweyn si loo arko waxa MDS-kaaga ka jawaabayo.
Aragtida waxay ku xirnaan doontaa nooca MDS iyo darnaanta calaamadaha. Caafimaadkaaga guud wuxuu sidoo kale saameyn ku yeelan karaa fursadahaaga soo kabashada. Dad badan ayaa qaba MDS deggan oo aan u gudubin kansar sannado, haddii ay weligood tahay.
Dadka qaarkiis ee qaba MDS waxaa laga yaabaa inay ku dhacaan myeloid leukemia daran (AML).
Dhibaatooyinka MDS waxaa ka mid ah:
- Dhiigbax
- Cudurrada sida oof-wareenka, infakshannada caloosha ku dhaca, infekshannada kaadi-mareenka
- Cudurka 'Myeloid leukemia' ee daran
La xiriir bixiyahaaga haddii aad:
- Dareen daciifnimo iyo daal badanaa
- Nabar nabar ama si fudud u dhiig, cirridka dhiig ka imaada ama dheecaanno sanka ka imanaya
- Waxaad dareemeysaa baro casaan ah ama guduud ah oo maqaarka hoostiisa ka dhiig baxaya
Xun-xumada Myeloid; Cudurka 'Myelodysplastic syndrome'; MDS; Cudurka 'Preleukemia'; Cudurka leukemia oo qiiqaya; Dhiig yaraan; Cytopenia diidan
Himilada dhuuxa lafta
Hasserjian RP, Madaxa DR. Cudurrada 'Myelodysplastic syndromes'. Gudaha: Jaffe ES, Arber DA, Campo E, Harris NL, Quintanilla-Martinez L, eds. Hematopathology. 2aad ed. Philadelphia PA: Elsevier; 2017: cutubka 45.
Websaydhka Machadka Kansarka Qaranka. Daaweynta neoplasms ee 'Myelodysplastic / myeloproliferative neoplasms' (PDQ) - nooca xirfad-yaqaannada caafimaadka. www.cancer.gov/types/myeloproliferative/hp/mds-mpd-treatment-pdq. La cusbooneysiiyay Febraayo 1, 2019. La helay Diseembar 17, 2019.
Steensma DP, Stone RM. Cudurrada 'Myelodysplastic syndromes'. Gudaha: Goldman L, Schafer AI, eds. Daawada Goldman-Cecil. 26aad. Philadelphia, PA: Elsevier; 2020: cutubka 172.